{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Transforming Pharma Workflows: AI-Driven Quality & Compliance with Chris Dayton","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/c97ae0d4\"></iframe>","width":"100%","height":180,"duration":2869,"description":"Chris Dayton, Co-Founder & CEO of Quality Assured AI, explores how AI is being responsibly integrated into the pharmaceutical industry, with a focus on quality management, regulatory compliance, and data security. He discusses the use of closed systems and air-gapped architectures to protect sensitive data, the challenges of deploying AI in regulated environments, and the importance of mitigating hallucinations in AI models. Chris also shares lessons from launching and scaling the platform, transitioning into the CEO role, and building AI literacy within organizations—highlighting how thoughtful AI adoption can drive innovation while reducing operational strain and burnout.\nChapters:\n00:00 Introduction to Quality Assured AI\n02:51 The Role of AI in Pharmaceuticals\n06:02 Understanding AI Implementation Challenges\n09:04 The Importance of Data Security\n11:50 Navigating Regulatory Compliance\n15:00 The Evolution of AI in Quality Management\n17:59 The Human Element in AI Integration\n20:56 Client Onboarding and Customization\n23:49 Feedback and Market Reception\n26:59 Future Growth and Scalability\n29:50 Parting Thoughts and Advice\nGuest Information:Guest's Name: Chris DaytonGuest's Title/Position:  Co-Founder & CEOGuest's Linkedin: https://www.linkedin.com/in/chris-dayton-b414bb57/Company / Affiliation: Quality Assured AI  https://www.qualityassured.ai/Guest's Bio: Chris Dayton is the Co-Founder and CEO of Quality Assured Ai, a company delivering closed-system, on-premise AI solutions purpose-built for pharmaceutical Quality Assurance and Quality Management. With over a decade of experience across protein, cell, and gene therapy manufacturing, he has served as a lead investigator, QMS author, and technical operations manager overseeing QDS authorship and validation approvals. Chris has designed and deployed AI/ML models that streamline deviation drafting, SOP generation, and CAPA support while maintaining strict compliance with FDA, EMA, and MHRA regulatory frameworks. He...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}